AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 813 | 29,448 | 760 | 0 | 0 |
| Gross Profit | 813 | 29,448 | 760 | N/A | N/A |
| Operating Expenses | 22,592 | 21,049 | 23,936 | 22,940 | 20,763 |
| Operating Income | -21,779 | 8,399 | -23,177 | -22,940 | -4,276 |
| Interest Expense | 34 | 38 | 38 | 41 | 32 |
| Other Income | 3,206 | -2,003 | -1,952 | 2,563 | -1,311 |
| Pre-tax Income | -18,607 | 6,359 | -25,166 | -20,418 | -5,619 |
| Income Tax | N/A | N/A | N/A | N/A | 8 |
| Net Income Continuous | -18,610 | 6,359 | -25,166 | -20,418 | -5,627 |
| Net Income | $-18,610 | $6,359 | $-25,166 | $-20,418 | $-5,620 |
| EPS Basic Total Ops | -0.19 | 0.07 | -0.25 | -0.21 | -0.06 |
| EPS Basic Continuous Ops | -0.19 | 0.06 | -0.25 | -0.21 | -0.06 |
| EPS Diluted Total Ops | -0.18 | 0.06 | -0.25 | -0.21 | -0.06 |
| EPS Diluted Continuous Ops | -0.18 | 0.06 | -0.25 | -0.21 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.18 | 0.06 | -0.25 | N/A | N/A |
| EBITDA(a) | $-21,210 | $9,066 | $-22,592 | $-22,304 | $-20,175 |